Trial NCT04542434

View at ClinicalTrials.gov 
Org. Study IDs: FW-COV-003

Last trial update was posted on 2022-02-21

MeSH Interventions

Niclosamide

MeSH Conditions

COVID-19

Other Conditions

Covid19

Stopping Reasons

Sponsor asset acquired by another pharma company who opened their own IND for this compound. First Wave Bio never started this study in the US or ex-US.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID